Piper Sandler on Axsome Therapeutics (AXSM): 'A High-Risk, High-Reward Opportunity'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem reiterated an Overweight rating and $223.00 price target on Axsome Therapeutics (NASDAQ: AXSM).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
